Rezipas
Brand names,
Rezipas
Analogs
Rezipas
Brand Names Mixture
Rezipas
Chemical_Formula
C7H7NO3
Rezipas
RX_link
http://www.rxlist.com/cgi/generic2/paser.htm
Rezipas
fda sheet
Rezipas
msds (material safety sheet)
Rezipas
Synthesis Reference
Biniecki S., et al. Acta Pol Pharm. 1967;24(5):469-73
Rezipas
Molecular Weight
153.135 g/mol
Rezipas
Melting Point
150.5 oC
Rezipas
H2O Solubility
1690 mg/L
Rezipas
State
Solid
Rezipas
LogP
1.012
Rezipas
Dosage Forms
Packet of coated granules
Rezipas
Indication
For the treatment of tuberculosis
Rezipas
Pharmacology
Aminosalicylic acid is an anti-mycobacterial agent used with other anti-tuberculosis drugs (most often isoniazid) for the treatment of all forms of active tuberculosis due to susceptible strains of tubercle bacilli. The two major considerations in the clinical pharmacology of aminosalicylic acid are the prompt production of a toxic inactive metabolite under acid conditions and the short serum half life of one hour for the free drug. Aminosalicylic acid is bacteriostatic against Mycobacterium tuberculosis (prevents the multiplying of bacteria without destroying them). It also inhibits the onset of bacterial resistance to streptomycin and isoniazid.
Rezipas
Absorption
No information avaliable
Rezipas
side effects and Toxicity
LD50=4 gm/kg (orally in mice); LD50=3650 mg/kg (orally in rabbits)
Rezipas
Patient Information
Rezipas
Organisms Affected
Mycobacteria